GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

DERM · Jun 30, 2025

Journey Medical Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001410578-25-001703General Corporate
Debt relative to revenue80thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.debt_to_revenue

167.31% · OPTIONAL · VALID

Operating cash generation73thOwn-history percentile · N=11
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-6.28% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

1.04% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure73thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

85.63% · OPTIONAL · VALID

Operating margin82thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.operating_margin

-19.16% · CORE · VALID

R&D intensity0thOwn-history percentile · N=11
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

0.00% · OPTIONAL · VALID

SBC intensity45thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

8.90% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History16 statesHistory building
Sep 30, 20220/6 normalizedLevel 3Dec 31, 20220/8 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20230/8 normalizedLevel 3Sep 30, 20230/9 normalizedLevel 3Dec 31, 20230/9 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20246/8 normalizedLevel 3Dec 31, 20247/9 normalizedLevel 3Mar 31, 20256/7 normalizedLevel 3Jun 30, 20256/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 3
Period transition

What moved in the state?

Balance Sheet Leverage Decreased
Previous
190.12%
Current
167.31%
Delta
-22.81%
Cash Generation Increased
Previous
-21.55%
Current
-6.28%
Delta
15.28%
Growth Increased
Previous
0.84%
Current
1.04%
Delta
0.20%
Inventory Pressure Decreased
Previous
95.11%
Current
85.63%
Delta
-9.48%
Profitability Increased
Previous
-25.30%
Current
-19.16%
Delta
6.14%
R And D Intensity Decreased
Previous
0.30%
Current
0.00%
Delta
-0.30%
Sbc Intensity Decreased
Previous
10.07%
Current
8.90%
Delta
-1.17%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · DERM Fundamental State →Transitioned To · DERM Fundamental State →Transitioned To · DERM BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · DERM CASH_GENERATION_INCREASED →Transitioned To · DERM GROWTH_INCREASED →Transitioned To · DERM INVENTORY_PRESSURE_DECREASED →Transitioned To · DERM PROFITABILITY_INCREASED →Transitioned To · DERM R_AND_D_INTENSITY_DECREASED →Transitioned To · DERM SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.